Elevated serum osteopontin levels in idiopathic retroperitoneal fibrosis

Clinical and Experimental Rheumatology

Volumn 30, Issue 5, 2012, Pages 772-775

  Binder, M ^a   Christoph, S ^a   Sehnert, B ^a   Uhl, M ^b   Peter, H H ^a   Voll, R E ^a   Warnatz, K ^a   Kollert, F ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b RKK Freiburg ^*  (Germany)

Author keywords

Biomarkers; C reactive protein; Erythrocyte sedimentation rate; Idiopathic retroperitoneal fibrosis; Osteopontin

Indexed keywords

OSTEOPONTIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC RETROPERITONEAL FIBROSIS; INFLAMMATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROPERITONEAL FIBROSIS; RETROSPECTIVE STUDY; SYMPTOMATOLOGY;

AORTA; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOCORTICOIDS; HUMANS; MAGNETIC RESONANCE IMAGING; OSTEOPONTIN; PREDICTIVE VALUE OF TESTS; RETROPERITONEAL FIBROSIS; RETROSPECTIVE STUDIES; UP-REGULATION;

EID: 84870268744     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. VAGLIO A, SALVARANI C, BUZIO C: Retroperitoneal fibrosis. Lancet 2006;367:241-51.
2. *03: another clue to an autoimmune origin. Arthritis Rheum 2006;55:12630.
3. VAN BOMMEL EF, JANSEN I, HENDRIKSZ TR, AARNOUDSE AL: Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore) 2009;88:193-201.
4. WARNATZ K, KESKIN AG, UHL M et al.: Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis 2005;64:82833.
5. MAGREY MN, HUSNI ME, KUSHNER I et al:. Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis? Arthritis Rheum 2009;61:674-79.
6. LENGA Y, KOH A, PERERA AS et al.: Osteopontin expression is required for myofibroblast differentiation. Circ Res 2008;102:319-27.
7. DENHARDT DT, NODA M, O'REGAN AW et al:. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001;107:1055-61.
8. PARDO A, GIBSON K, CISNEROS J et al:. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med 2005;2:e251.
9. LORENZEN JM, KRÄMER R, MEIER M et al:. Osteopontin in the development of systemic sclerosis - relation to disease activity and organ manifestation. Rheumatology (Oxford) 2010;49:1989-91.
10. PRASSE A, STAHL M, SCHULZ G et al:. Essential role of osteopontin in smoking-related interstitial lung diseases. Am J Pathol 2009;174:1683-91.
11. MORI R, SHAW TJ, MARTIN P: Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med 2008;205:43-51.
12. KOTTRA JJ, DUNNICK NR: Retroperitoneal fibrosis. Radiol Clin North Am 1996;34:1259-75.
13. KUROKAWA M, KONNO S, MATSUKURA S et al.: Effects of corticosteroids on osteopontin expression in a murine model of allergic asthma. Int Arch Allergy Immunol 2009;149(Suppl. 1):7-13.
14. LEBOY PS, BERESFORD JN, DEVLIN C, OWEN ME: Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures. J Cell Physiol 1991;3:370-8.
15. MORIMOTO J, KON S, MATSUI Y, UEDE T: Osteopontin; as a target molecule for the treatment of inflammatory diseases. Curr Drug Targets 2010;4:494-505.
16. KOSHIKAWA M, AIZAWA K, KASAI H et al: Elevated osteopontin levels in patients with peripheral arterial disease. Angiology 2009;60:42-5.
17. UIBU T, OKSA P, AUVINEN A et al:. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet 2004;363:1422-6.
18. BRANDT AS, KAMPER L, KUKUK S, HAAGE P, ROTH S: Associated findings and complications of retroperitoneal fibrosis in 204 patients: results of a urological registry. J Urol 2011;185:526-31.